3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the target of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 14,802,882 shares, a growth of 142.1% from the June 30th total of 6,115,388 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
3SBio Price Performance
Shares of 3SBio stock opened at $2.15 on Thursday. The business has a fifty day simple moving average of $2.25 and a two-hundred day simple moving average of $2.65. 3SBio has a 1 year low of $2.00 and a 1 year high of $4.74.
3SBio Company Profile
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
See Also
- Five stocks we like better than 3SBio
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
